Announced
Completed
AstraZeneca, CR Capital Magament and Panlin capital led a $50m Series B round in NuProbe.
Synopsis
AstraZeneca, CR Capital Magament and Panlin capital led a $50m Series B round in NuProbe, a biotechnology company, with participation from Gaorong Capital, Deguan Capital, Pappas Capital, BioTrack Capital, Sequoia, Yonghua Capital and Tuobang Capital.
Principals
Show Details & Financials
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
No credit card required
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.